Arriva Pharmaceuticals Names New General Counsel, Gregory J Ikonen

Posted on May 26, 2008 in Medicine news

Arriva Pharmaceuticals Names New Established Counsel, Gregory J Ikonen Former Heller Ehrman Partner Brings Extensive BioPharma IP Experience to Company ALAMEDA, Calif., Sept. 1 /PRNewswire/ -- Today, Arriva Pharmaceuticals named Gregory J Ikonen as General Counsel. Mr. Ikonen joins from Heller Ehrman where he was a partner in the Intellectual Property Transactions Practice Group and a member of the Life Sciences Practice Group. He assumes his position as Arriva enters its next phase of growth. Mr. Ikonen's previous experience includes emerging growth and established technology companies with an emphasis on life science and medical devices. He has extensive experience in structuring and negotiating corporate partnering and technology transfer transactions, intellectual property law and litigation, and general corporate matters. Prior to joining Heller Ehrman, Mr. Ikonen was a director at Venture Law Group. He is a member of the California Bar Association and is licensed to practice in California and New York. He graduated from the University of Michigan with a B.S. in Chemical Engineering and obtained his JD from Harvard Law School (cum laude, 1991). "Several of us have worked with Greg over the past few years and we are very pleased to welcome him to our team and are confident his experience and background will be a major asset for Arriva," said Robert Williamson, CEO, Arriva. About Arriva: Arriva Pharmaceuticals, Inc., is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, chronic obstructive pulmonary disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva has been funded by individual seed investors, corporate partners and venture investors including: MPM Capital, AIG Global Investments, CIBC Capital Partners, Baxter Healthcare Corporation, MedImmune Ventures and ProMetic Life Sciences. Company headquarters are in Alameda, California. For additional information please visit: http://www.arrivapharm.com/ Source: Arriva Pharmaceuticals, Inc. CONTACT: Matthew Dean, +1-510-337-7883, mdean@arrivapharm.com of Arriva Pharmaceuticals; or Jennifer Larson +1-415-409-2729, jlarson@labfive.com for Arriva Pharmaceuticals Web site: http://www.arrivapharm.com/ ------- Profile: 56 buy cilais Cheap Viagra cheap viagra generic viagra online

Tags: arriva, pharmaceuticals, ikonen, partner, company

Sponsors

Search